Sign Out
Active immunisation against encephalitis due to Japanese encephalitis virus
Adult: As adsorbed, inactivated virus vaccine: Primary immunisation: 0.5 mL at 0 and 28 days. Alternatively, an accelerated schedule consisting of 0.5 mL at 0 and 7 days may be given when there is insufficient time for the standard course. Primary course should be completed at least 1 week before potential exposure. Booster dose: Given 12-24 months (12 months for those at continued risk) after the primary course.
Child: Primary immunisation: 2 months to <3 years 0.25 mL at 0 and 28 days; ≥3-17 years Same as adult dose. Booster dose: Given 12-24 months (12 months for those at continued risk) after the primary course.
Child: Primary immunisation: 2 months to <3 years 0.25 mL at 0 and 28 days; ≥3-17 years Same as adult dose. Booster dose: Given 12-24 months (12 months for those at continued risk) after the primary course.
Subcutaneous
Active immunisation against encephalitis due to Japanese encephalitis virus
Adult: As live, attenuated virus vaccine: Primary immunisation: 0.5 mL as single dose. Booster dose: May be given 5 years after the primary dose, in patients at continued risk.
Child: 9 months to 17 years Primary immunisation: 0.5 mL as single dose. Booster dose: Given 12-24 months after the primary dose, in patients at continued risk.
Child: 9 months to 17 years Primary immunisation: 0.5 mL as single dose. Booster dose: Given 12-24 months after the primary dose, in patients at continued risk.
